A Novel Anti-CD47 Nanobody Tetramer for Cancer Therapy
CD47 acts as a defense mechanism for tumor cells by sending a “don’t eat me” signal via its bond with SIRPα. With CD47’s overexpression linked to poor cancer outcomes, its pathway has become a target in cancer immunotherapy. Though monoclonal antibodies offer specificity, they have limitations like...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
MDPI AG
2024-01-01
|
| Schriftenreihe: | Antibodies |
| Schlagworte: | |
| Online-Zugang: | https://www.mdpi.com/2073-4468/13/1/2 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|